PDS Biotechnology Corp (PDSB)
Healthcare
Biotechnology
0.69 $
-1.8%
vs. previous close
Closing price · As of: 31. Jul 2026
PDS Biotechnology Corp (PDSB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -27,752 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.7 | -22 | -32 | -41 | -33 | -18 | -13 | -12 | -26 | -34 | -35 | -27,752 | |
| 0.0 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1,554 | |
| 1.3 | 2.9 | 5.3 | 6.4 | 7.6 | 3.2 | 0.5 | 4.1 | 5.2 | 7.6 | 6.8 | 4,107 | |
| – | – | 0.5 | 0.4 | 1.1 | -6.6 | 0.6 | 4.4 | 5.2 | – | – | – | |
| 1.7 | 1.3 | 0.8 | 3.1 | -3.4 | -4.6 | 1.1 | 0.1 | 4.5 | -0.2 | -5.8 | -0.4 | |
| 0.9 | 1.3 | 0.7 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -0.9 | -1.3 | -0.7 | -0.2 | 29 | 29 | – | – | – | – | 0.0 | – | |
| – | – | – | – | – | – | – | – | 0.0 | – | – | – | |
| – | 138 | 0.3 | 18 | 0.7 | 0.8 | 30 | – | 0.0 | – | – | – | |
| – | – | 1.4 | 0.0 | 0.0 | 25 | 25 | 25 | 25 | -0.1 | -3.2 | -7.6 | |
| 16 | 140 | 9.1 | 23 | -20 | 0.8 | 30 | 49 | 34 | 16 | 20 | 12,774 | |
| 5.9 | 116 | -24 | -18 | -53 | 12 | 17 | 36 | 8.6 | -17 | -15 | -14,978 | |
| -11 | -23 | -33 | -41 | -33 | -18 | -13 | -12 | -26 | -34 | -35 | -27,752 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.